- BNF:
- Not listed
- Status:
- Do Not Prescribe (DNP), Red
- Decision Date:
- February 2024
Comments
RED: NICE HST30: for treating Wolman disease as per NHSE commissioning intentions (Decision date - February 2024)
DNP: NICE TA961: for treating lysosomal acid lipase deficiency that is not Wolman disease. (Terminated Appraisal). (Decision date - April 2024)
Red Drug Classifications
- 1: Requiring specialist assessment to enable patient selection, initiation and ongoing treating
- 2: Requiring long term on-going monitoring of efficacy by a specialist and not suitable for shared care
search again